Meta-analysis of the clinicopathological significance of miRNA-145 in breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Meta-analysis of the clinicopathological significance of miRNA-145 in breast cancer
Authors
Keywords
-
Journal
BIOSCIENCE REPORTS
Volume 40, Issue 9, Pages -
Publisher
Portland Press Ltd.
Online
2020-09-01
DOI
10.1042/bsr20193974
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-145-targeted HBXIP modulates human breast cancer cell proliferation
- (2018) Yang Jiang et al. Thoracic Cancer
- Candidate miRNAs in human breast cancer biomarkers: a systematic review
- (2017) Masoumeh Adhami et al. Breast Cancer
- A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer
- (2017) Ji-Guang Han et al. Annals of Surgical Treatment and Research
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer
- (2016) Seema Thakur et al. PLoS One
- MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1
- (2015) Meizhu Zheng et al. TUMOR BIOLOGY
- Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: A case control study
- (2014) Annette R. Kodahl et al. Molecular Oncology
- Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers
- (2013) Fermín Mar-Aguilar et al. DISEASE MARKERS
- MicroRNAs in Human Placental Development and Pregnancy Complications
- (2013) Guodong Fu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
- (2013) Enders K. O. Ng et al. PLoS One
- Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells
- (2013) Tissa T. Manavalan et al. PLoS One
- MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF
- (2012) Chao Zou et al. CELL CYCLE
- MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-à-go-go (EAG1)
- (2012) Yifeng Bai et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
- (2011) Jelena Radojicic et al. CELL CYCLE
- Micromarkers: miRNAs in cancer diagnosis and prognosis
- (2010) Manuela Ferracin et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Biogenesis of small RNAs in animals
- (2009) V. Narry Kim et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation